N/A
Completed N=86
VerTouch Device: A Prospective Randomized Controlled Trial
Source: ClinicalTrials.gov NCT04630171 ↗Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcomePrimary: Number of Redirections of the Needle — .72; 2.81; 2.35 Number of redirections of needle
Summary
This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Redirections of the Needle |
.72; 2.81; 2.35 | — |
| SECONDARY Number of Reinsertions of the Needle |
.11; .96; .5 | — |
| SECONDARY Total Procedure Time |
8.66; 9.81; 7.88 | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients 18 years old and above
- Undergoing a neuraxial procedure
Exclusion Criteria
- Non English speaking
- Plastic allergy
- Unable to provide written informed consent
Data sourced from ClinicalTrials.gov (NCT04630171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.